Dublin, July 25, 2017 (GLOBE NEWSWIRE) -- The "Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022" report has been added to Research and Markets' offering.
It is predicted that by 2022, the global Point-of-Care testing market will reach U$ 30 Billion.
This report provides a detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight about the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market.
Furthermore, few challenges, such as product recalls and lack of regulatory standards, hindering the growth of the global Point-of-Care testing market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Point-of-Care testing market. Various trends and developments in the industry have also been cited in the report.
The global Point-of-Care testing market has been segmented on the basis of type of product. The major types of Point-of-Care testing present in the market include glucose monitoring kits, blood gas and electrolyte analysers, pregnancy & fertility testing kits, cardiac markers, infectious diseases testing kits, coagulation monitoring kits and drug-of-abuse testing kits amongst others.
According to the report, glucose monitoring kits accounted for the largest share in 2016 due rising prevalence of diabetes & technological advancements in self-monitoring of blood glucose. Based on geography, the report divides the market into North America, Europe, Asia-Pacific, and Rest of the World. In 2016, North America accounted for the largest share.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Point-of-Care Diagnostics: An Overview
5. Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Infectious and Lifestyle Related Diseases
5.1.2 Rising Use of Home Based Point-of-Care Diagnostics
5.1.3 Government Initiatives
5.1.4 Technological Advancements
5.1.5 Rising FDA Approvals
5.1.6 Lack of Skilled Lab Personnel
5.1.7 Rising Awareness about POCT
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Lack of Regulatory Standards
5.2.3 Data Management & Connectivity
5.3 Market Opportunities
5.3.1 Physical Robotic Telepresence
5.3.2 Smart Virtual Assistant in Association with Mobile Devices
6. Point-of-Care Testing Market Outlook 2022
7. Point-of-Care Testing Market, By Product
7.1.1 Glucose Monitoring Kits
7.1.2 Blood Gas and Electrolyte Analyzers
7.1.3 Pregnancy & Fertility Testing Kits
7.1.4 Cardiac Markers
7.1.5 Infectious Diseases Testing Kits
7.1.6 Drug-of-Abuse Testing Kits
8. Point-of-Care Testing Market, By Region
8.1.1 North America
8.1.3 Asia Pacific
8.1.4 Rest of the World
9. Industry Trends and Developments
9.1 Portable Ultrasound Providing Care on Site
9.2 Microfluidics Technology Crowding the POCT Industry
10. Company Profiles
10.1 Becton, Dickinson and Company
10.2 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
10.3 Siemens Healthineers
10.4 Danaher Corporation
10.5 Abbott Laboratories
10.6 Johnson & Johnson
10.7 OraSure Technologies, Inc.
10.8 Thermo Fisher Scientific Inc.
10.9 Medtronic plc
10.10 Alere Inc
For more information about this report visit https://www.researchandmarkets.com/research/r4j7hl/global_point_of
CONTACT: CONTACT: Research and Markets Laura Wood, Senior Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Women's Health, Point-of-Care Diagnostics, Infectious Disease Testing, Maternal and Neonatal Care